Observational analysis highlights advances in structural biology and drug design, suggesting progress in biotechnology.
About 100 years ago, the field of structural biology was born, led by James B. Sumner who recognized that enzymes were molecules with specific functions. In its contemporary form structural biology is used to interpret and understand molecular and cellular function, to design drugs, and to advance biotechnology in general.
No takes yet. Share an insight, caveat, or question.
Jr et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: